Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
申请人:Genentech, Inc.
公开号:EP1754705A2
公开(公告)日:2007-02-21
The invention provides novel compounds that are useful for treating Mac-1 or LFA-1-mediated disorders such as inflammatory disorders, allergies, and autoimmune diseases.